ClinicalTrials.gg
Not yet recruitingNCT06654765Updated Oct 23, 2024

Growth and Development of Children With Inborn Errors of Metabolism in Assiut Governorate

An observational study in Inborn Errors of Metabolism, sponsored by Assiut University. Not yet recruiting at 1 site in Egypt. Open to participants aged 1 Month to 5 Years. Per ClinicalTrials.gov, last updated 2024-10-23.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
201
Ages
1 Month to 5 Years
Sex
All
01

Study summary

Assessment of growth and development of children with inborn errors of metabolism in Assiut Governorate

Read the detailed description

Inborn errors of metabolism (IEM) are diseases resulting in deficient activity of an individual enzyme, structural protein in an intermediate metabolic pathway, present clinically in a wide variety of ways a ranging from non-specific chronic issues such as childhood delay in attaining development milestones, to acute decompensation.

The prevalence of all of inborn errors of metabolism globally is 50.9/100000 live birth, In Egypt the prevalence among clinically suspected children is 7.8%.

A study conducted in Minia Governorate (Egypt) on children less than 18 years included 67 children showed that 65.7% of children were under height. Also a study conducted in upper Egypt on 113 PKU patients showed that global developmental delay 54.9% was the most frequent presentations of PKU children. Parents of children with IEM face many challenges; as the financial burden and perceived restrictions in all aspects of life, discrimination by society in general, and the main challenge is dietary restrictions.

Rationale:

Despite being rare in Egypt, IEM are regarded as a national priority because of the substantial health burden they place on the growth and development of the affected children, which can range from delayed achievement of developmental milestones to acute decompensation and death.

However, there is lack of longitudinal studies in Egypt that focus on how IEM affect physical development and growth, as well as the difficulties parents encounter while caring for their children and following up with them. To our knowledge, no local studies have been conducted in this field before.

02

Conditions studied

  • Inborn Errors of Metabolism

Keywords

  • Growth
  • Development
  • IEM
  • Assiut
03

In context

Metabolism, Inborn Errors

152 studies on the registry are indexed under Metabolism, Inborn Errors; 22 are open to participants now.

This study's planned enrollment of 201 is above the median of 65 across 45 observational studies indexed under Metabolism, Inborn Errors.

Browse Metabolism, Inborn Errors studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Under five years old children with confirmed diagnosis of IEM who are attending the study settings

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Under five years old children with confirmed diagnosis of IEM.
  • Attending the study settings.

Exclusion criteria

Exclusion Criteria:

  • Patients diagnosed since birth with dysmorphic features.
  • Patients diagnosed since birth with congenital anomalies.
  • Patients with other neurological deficits (e.g. cerebral palsy, convulsions, birth anoxia.....)
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
201 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. • To assess weight (in kilograms) of children with IEM in Assiut governorate.

    The weight will be measured to the nearest 0.1Kg and the patients in light clothes and bare feet. The child weight will be measured and the measurements will be plotted on the Egyptian growth charts of girls and boys for different ages from birth to five years old in order to assess their growth.

    Time frame: 1 year

  2. • To assess height (in meters) of children with IEM in Assiut governorate.

    If the child is less than 2 years old or is unable to stand recumbent length will be measured to the nearest 0.1 cm. If the child is aged 2 years or older and able to stand, standing height will be measured to the nearest 0.1 cm. The child height will be measured and the measurements will be plotted on the Egyptian growth charts of girls and boys for different ages from birth to five years old in order to assess their growth.

    Time frame: 1 year

  3. • To assess the body mass index for age (BMI for age in kg/m^2) of children with IEM in Assiut governorate.

    Body mass index for age (BMI for age) will be calculated in kg/m\^2 and plotted on the Egyptian growth charts of girls and boys for different ages from birth to five years old in order to assess their growth.

    Time frame: 1 year

  4. To assess development of children with IEM in Assiut governorate using the arabic version of the third edition of the Ages and Stages Questionnaires.

    The Arabic version of the third edition of the Ages \& Stages Questionnaires (ASQ-3) will be used to identify developmental growth in children from one month to five and a half years . it measures development in 5 key domains: communication, gross motor, fine motor, problem solving, and personal-social domain. Each response on the questionnaire will be converted to a numerical value (usually equal to 10, occasionally to 5, and not yet to 0) in order to determine the score, then each domain's overall score will be summed. ASQ-3 has three scoring zones and the higher the score the better the child development for each developmental area separately.

    Time frame: 1 year

  5. • To assess knowledge of the mother regarding the child metabolic disease and dietary recommendations using a questionnaire to be designed.

    Knowledge regarding the child inborn metabolic diseases such as disease definition, symptoms necessitate immediate hospital admission, disease complications, dietary requirement and restrictions.

    Time frame: 1 year

  6. Assessment of mother's practice using a questionnaire to be designed.

    Dietary practice, child care, vaccination and follow up.

    Time frame: 1 year

07

Study locations

1 site
  • • Genetic counselling center at Al Weladea neighbourhood in Assiut governorate. • Genetics Center at Al-Iman General Hospital in Assiut governorate. • Genetics clinic at Assiut University paediatrics' hospital.
    Assiut, Egypt
08

References and documents

Publications

  • Duggan C, Irvine AD, O'B Hourihane J, Kiely ME, Murray DM. ASQ-3 and BSID-III's concurrent validity and predictive ability of cognitive outcome at 5 years. Pediatr Res. 2023 Oct;94(4):1465-1471. doi: 10.1038/s41390-023-02528-y. Epub 2023 Feb 25. PubMed 36841883 ↗
  • El Shafie AM, El-Gendy FM, Allahony DM, Hegran HH, Omar ZA, Samir MA, Kasemy ZA, El-Bazzar AN, Abd El-Fattah MA, Abdel Monsef AA, Kairallah AM, Raafet HM, Baza GM, Salah AG, Galab WS, Alkalash SH, Salama AA, Farag NA, Bahbah WA. Development of LMS and Z Score Growth References for Egyptian Children From Birth Up to 5 Years. Front Pediatr. 2021 Jan 18;8:598499. doi: 10.3389/fped.2020.598499. eCollection 2020. PubMed 33537262 ↗
  • Padeniya RN, Thushari G, Nissanka DH, Shashika C, Munasinghe DH, Aberathne DM, Weerawardena PL, Galgamuwa LS, Kumarasinghe N, Liyanage L. Maternal coping strategies in response to child's oncological diseases in Sri Lanka. Acta Oncol. 2020 Jul;59(7):866-871. doi: 10.1080/0284186X.2020.1750695. Epub 2020 Apr 14. PubMed 32286131 ↗
  • Waters D, Adeloye D, Woolham D, Wastnedge E, Patel S, Rudan I. Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence. J Glob Health. 2018 Dec;8(2):021102. doi: 10.7189/jogh.08.021102. PubMed 30479748 ↗
  • Agana M, Frueh J, Kamboj M, Patel DR, Kanungo S. Common metabolic disorder (inborn errors of metabolism) concerns in primary care practice. Ann Transl Med. 2018 Dec;6(24):469. doi: 10.21037/atm.2018.12.34. PubMed 30740400 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06654765
Lead sponsor
Assiut University
Responsible party
Samar Abd El-mohsen Mahfouz (Assistant lecturer, Assiut University) — Principal investigator
First posted
Oct 23, 2024
Start date
Aug 2025 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 23, 2024

Study contacts

Samar Mahfouz, assistant lecturer
Contact
samarmohsen2030@gmail.com
01006534339
Sabra Mohamed Ahmed, Prof. Dr
study director · Assiut University
Taghreed Abdel-Aziz Mohamed, Prof. Dr
study director · Assiut University
Samar Mahfouz, assistant lecturer
principal investigator · Assiut University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion